References
- Klastrup V, Hvass AM, Mackenhauer J, CONSIDER Sepsis Network, et al. Site of infection and mortality in patients with severe sepsis or septic shock. A cohort study of patients admitted to a Danish general intensive care unit. Infect Dis (Lond). 2016;48:726–731.
- Denis E, Martis N, Guillouet-de Salvador F, et al. Bacteraemic urinary tract infections may mimic respiratory infections: a nested case-control study. Eur J Clin Microbiol Infect Dis. 2016;35:1601–1605.
- Alexander C, Rietschel ET. Bacterial lipopolysaccharides and innate immunity. J Endotoxin Res. 2001;7:167–202.
- Heumann D, Roger T. Initial responses to endotoxins and Gram-negative bacteria. Clin Chim Acta. 2002;323:59–72.
- Chuang TY, Cheng AJ, Chen IT, et al. Suppression of LPS-induced inflammatory responses by the hydroxyl groups of dexamethasone. Oncotarget. 2017;8:49735–49748.
- Vassallo M, Mercié P, Cottalorda J, et al. The role of lipopolysaccharide as a marker of immune activation in HIV-1 infected patients: a systematic literature review. Virol J. 2012;9:174.
- De Gaudio AR, Rinaldi S, Chelazzi C, et al. Pathophysiology of sepsis in the elderly: clinical impact and therapeutic considerations. Curr Drug Targets. 2009;10:60–70.